There are scenarios where a 1:1 or a 1.5:1 scrip offer would result in an increase in Earnings Per Share for ADN shareholders. One factor is the cash boost from cash held by MEP moving into ADN coffers ( less dilution when ADN gets to point of funding the project ).
I think a 1:1 scenario would boost EPS for ADN shareholders by up to 18%.
I think a 1:1.5 scenario would boost EPS for MEO shareholders by up to 8%.
Partly comes down to timing for funding ( optimally after a merger ).
ADN shareholders would get a boost in earnings per share.
MEP shareholders would get a quick boost in the value of their shares.
There are scenarios where a 1:1 or a 1.5:1 scrip offer would...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.002(9.52%) |
Mkt cap ! $59.09M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $33.38K | 1.726M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1823487 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1122200 | 3 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| ADN (ASX) Chart |